Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Dex closes $5.3m matching ML talent

2 min read
16:30UTC

Dex closed a $5.3m seed on Tuesday 28 April from Notion Capital, a16z Speedrun, Concept Ventures and OpenAI angels at $1.8m of annualised recurring revenue, matching machine-learning engineers to clients including Granola, Synthesia and ElevenLabs.

TechnologyDeveloping
Key takeaway

Dex closed $5.3m on 28 April at $1.8m ARR with Notion Capital and OpenAI angels.

Dex closed a $5.3 million seed on 28 April 2026 with $1.8 million of ARR (annualised recurring revenue)⁠1. Notion Capital led; a16z Speedrun, Concept Ventures and angels from OpenAI participated. The London platform matches machine-learning engineers to clients including Granola, Synthesia and ElevenLabs.

Dex's syndicate is the post-VCT-cut investor map at the AI talent tier in pure form. Notion Capital plus a16z Speedrun plus Concept Ventures plus OpenAI angels reads as a syndicate built for AI-native bets at the seed stage; retail-investor pools from the relief regime that closed earlier in April do not appear. OpenAI angels in particular write into companies that touch the model layer or its labour market, and Dex's product is an explicit hire-side bet on that labour market.

Granola's presence as a Dex client is a data point on the density of London's AI ecosystem. The note-taking unicorn raised $125m at a $1.5bn valuation in March and is now sourcing ML talent through a London-based platform that itself has British investors and American operator angels, which is the kind of within-cluster flow that turns regional density into a moat.

The ARR-to-round ratio also matters. $1.8m of ARR against a $5.3m seed implies a multiple in the high single digits, modest by AI-platform standards and consistent with a syndicate that is pricing on operator-network economics rather than topline growth. The bet is that OpenAI angels and Notion Capital can route demand from their portfolios; the cheque is paying for the network advantage the platform inherits.

Deep Analysis

In plain English

Dex helps companies hire machine-learning engineers, the specialists who build and maintain AI systems. Instead of posting job adverts on LinkedIn, companies pay Dex to match them with vetted ML engineers who are open to new work. At $1.8m in annualised recurring revenue, Dex already has paying customers. The $5.3m seed raised on 28 April funds growth of the matching platform, including the team needed to vet more engineers and serve more clients. OpenAI investors joined the round, which signals that Dex's client network overlaps with companies building products on OpenAI's technology. Those companies are among the fastest-growing engineering employers in the UK right now, and OpenAI benefits when its customers can hire AI talent faster.

First Reported In

Update #3 · SAIU rides $1.1bn Ineffable seed; hardware looms

Fortune· 1 May 2026
Read original →
Causes and effects
This Event
Dex closes $5.3m matching ML talent
The cap table demonstrates how international AI-native investors and operator angels are filling the seed-stage gap that retail VCT networks no longer serve.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.